Conservest Capital Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$392K Buy
1,083
+33
+3% +$11.3K 0.03% 96
2026
Q1
$369K Buy
1,050
+18
+2% +$6.42K 0.03% 91
2025
Q4
$338K Sell
1,032
-7
-0.7% -$2.22K 0.03% 96
2025
Q3
$293K Sell
1,039
-4
-0.4% -$1.16K 0.03% 101
2025
Q2
$291K Buy
1,043
+17
+2% +$4.82K 0.03% 102
2025
Q1
$320K Hold
1,026
0.03% 86
2024
Q4
$267K Buy
1,026
+175
+21% +$51.9K 0.03% 95
2024
Q3
$242K Hold
851
0.02% 97
2024
Q2
$242K Hold
851
0.03% 96
2024
Q1
$242K Hold
851
0.02% 97
2023
Q4
$245K Hold
851
0.03% 93
2023
Q3
$229K Buy
+851
New +$212K 0.03% 91
2023
Q2
Sell
-851
Closed -$206K 103
2023
Q1
$206K Hold
851
0.02% 93
2022
Q4
$224K Buy
+851
New +$228K 0.03% 83
2022
Q3
Sell
-851
Closed -$207K 91
2022
Q2
$207K Hold
851
0.03% 85
2022
Q1
$206K Buy
+851
New +$196K 0.02% 82
2021
Q3
Sell
-851
Closed -$207K 82
2021
Q2
$207K Hold
851
0.02% 79
2021
Q1
$212K Buy
+851
New +$203K 0.02% 76
2020
Q4
Sell
-851
Closed -$216K 77
2020
Q3
$216K Hold
851
0.03% 70
2020
Q2
$201K Buy
+851
New +$194K 0.03% 69
2020
Q1
Sell
-851
Closed -$205K 70
2019
Q4
$205K Buy
+851
New +$188K 0.03% 78
2018
Q4
Sell
-1,828
Closed -$379K 81
2018
Q3
$379K Hold
1,828
0.06% 64
2018
Q2
$337K Sell
1,828
-1,325
-42% -$234K 0.05% 64
2018
Q1
$537K Hold
3,153
0.12% 47
2017
Q4
$548K Buy
3,153
+12
+0.4% +$2.12K 0.11% 47
2017
Q3
$586K Buy
3,141
+11
+0.4% +$1.95K 0.09% 55
2017
Q2
$539K Buy
3,130
+13
+0.4% +$2.11K 0.11% 44
2017
Q1
$511K Buy
+3,117
New +$518K 0.11% 46

Other funds holding AMGN

Conservest Capital Advisors's AMGN Position: Q2 2026 in Review

Conservest Capital Advisors increased its Amgen (AMGN) stake by 3.1% in Q2 2026, buying an estimated $11.3K and bringing the position to 1,083 shares worth $392K. The position accounts for 0.03% of the portfolio, ranked #96.

Conservest Capital Advisors first reported a position in AMGN in Q1 2017 and has held it in 28 quarters since. The position peaked at $586K in Q3 2017. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Conservest Capital Advisors held 1,083 shares of Amgen worth $392K as of Q2 2026.
  • Conservest Capital Advisors bought 33 Amgen shares in Q2 2026, an estimated $11.3K.
  • Amgen made up 0.03% of Conservest Capital Advisors's portfolio in Q2 2026, its #96 holding.
  • Conservest Capital Advisors first reported a position in Amgen in Q1 2017 and has held it in 28 quarters since.
  • Conservest Capital Advisors's Amgen position peaked at $586K in Q3 2017.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Conservest Capital Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.